Canipe Ashley, Chidumayo Takondwa, Blevins Meridith, Bestawros Michael, Bala Jay, Kelly Paul, Filteau Suzanne, Shepherd Bryan E, Heimburger Douglas C, Koethe John R
Vanderbilt Institute for Global Health, Nashville, TN, USA.
BMC Infect Dis. 2014 Sep 29;14:521. doi: 10.1186/1471-2334-14-521.
Undernourished, HIV-infected adults in sub-Saharan Africa have high levels of systemic inflammation, which is a risk factor for mortality and other adverse health outcomes. We hypothesized that microbial translocation, due to the deleterious effects of HIV and poor nutrition on intestinal defenses and mucosal integrity, contributes to heightened systemic inflammation in this population, and reductions in inflammation on antiretroviral therapy (ART) accompany reductions in translocation.
HIV-infected, Zambian adults with a body mass index <18.5 kg/m2 were recruited for a pilot study to assess the relationships between microbial translocation and systemic inflammation over the first 12 weeks of ART. To assess microbial translocation we measured serum lipopolysaccharide binding protein (LBP), endotoxin core IgG and IgM, and soluble CD14, and to assess intestinal permeability we measured the urinary excretion of an oral lactulose dose normalized to urinary creatinine (Lac/Cr ratio). Linear mixed models were used to assess within-patient changes in these markers relative to serum C-reactive protein (CRP), tumor necrosis factor-α receptor 1 (TNF-α R1), and soluble CD163 over 12 weeks, in addition to relationships between variables independent of time point and adjusted for age, sex, and CD4+ count.
Thirty-three participants had data from recruitment and at 12 weeks: 55% were male, median age was 36 years, and median baseline CD4+ count was 224 cells/μl. Over the first 12 weeks of ART, there were significant decreases in serum levels of LBP (median change -8.7 μg/ml, p = 0.01), TNF-α receptor 1 (-0.31 ng/ml, p < 0.01), and CRP (-3.5 mg/l, p = 0.02). The change in soluble CD14 level over 12 weeks was positively associated with the change in CRP (p < 0.01) and soluble CD163 (p < 0.01). Pooling data at baseline and 12 weeks, serum LBP was positively associated with CRP (p = 0.01), while endotoxin core IgM was inversely associated with CRP (p = 0.01) and TNF-α receptor 1 (p = 0.04). The Lac/Cr ratio was not associated with any serum biomarkers.
In undernourished HIV-infected adults in Zambia, biomarkers of increased microbial translocation are associated with high levels of systemic inflammation before and after initiation of ART, suggesting that impaired gut immune defenses contribute to innate immune activation in this population.
撒哈拉以南非洲地区营养不良的HIV感染成年人存在高水平的全身炎症,这是死亡和其他不良健康结局的一个危险因素。我们推测,由于HIV和营养不良对肠道防御及黏膜完整性的有害影响,微生物易位导致了该人群全身炎症加剧,而抗逆转录病毒治疗(ART)使炎症减轻伴随着易位减少。
招募体重指数<18.5 kg/m²的赞比亚HIV感染成年人进行一项试点研究,以评估ART治疗的前12周内微生物易位与全身炎症之间的关系。为评估微生物易位,我们测量了血清脂多糖结合蛋白(LBP)、内毒素核心IgG和IgM以及可溶性CD14;为评估肠道通透性,我们测量了经尿肌酐标准化的口服乳果糖剂量的尿排泄量(乳糖/肌酐比值)。使用线性混合模型评估这些标志物在患者体内相对于血清C反应蛋白(CRP)、肿瘤坏死因子-α受体1(TNF-α R1)和可溶性CD163在12周内的变化,以及独立于时间点且经年龄、性别和CD4⁺细胞计数调整的变量之间的关系。
33名参与者有招募时和12周时的数据:55%为男性,中位年龄为36岁,中位基线CD4⁺细胞计数为224个/μl。在ART治疗的前12周内,血清LBP水平(中位变化-8.7 μg/ml,p = 0.01)、TNF-α受体1(-0.31 ng/ml,p < 0.01)和CRP(-3.5 mg/l,p = 0.02)显著下降。12周内可溶性CD14水平的变化与CRP(p < 0.01)和可溶性CD163(p < 0.01)的变化呈正相关。汇总基线和12周时的数据,血清LBP与CRP呈正相关(p = 0.01),而内毒素核心IgM与CRP(p = 0.01)和TNF-α受体1(p = 0.04)呈负相关。乳糖/肌酐比值与任何血清生物标志物均无关联。
在赞比亚营养不良的HIV感染成年人中,微生物易位增加的生物标志物在ART治疗前后均与高水平的全身炎症相关,这表明肠道免疫防御受损导致了该人群的先天性免疫激活。